SEC FORM 4CLUSTER · 5 INSIDERS
$87,745,772.00
ADARx Pharmaceuticals, Inc. (ADRX)
Purchase of 5,161,516 shares across 5 reporting persons.
Transaction Code P · Reporting Persons 5
- George SimeonPurchase of 592,593 shares at $17.00 per share.$10,074,081.00
- George SimeonPurchase of 414,814 shares at $17 per share.$7,051,838.00
- George SimeonPurchase of 592,593 shares at $17 per share.$10,074,081.00
- SR ONE CAPITAL MANAGEMENT, LLCPurchase of 592,593 shares at $17.00 per share.$10,074,081.00
- SR ONE CAPITAL MANAGEMENT, LLCPurchase of 414,814 shares at $17 per share.$7,051,838.00
- SR ONE CAPITAL MANAGEMENT, LLCPurchase of 592,593 shares at $17 per share.$10,074,081.00
- ORBIMED ADVISORS LLCPurchase of 300,249 shares at $17.00 per share.$5,104,233.00
- ORBIMED ADVISORS LLCPurchase of 61,516 shares at $17.00 per share.$1,045,772.00
- ORBIMED ADVISORS LLCPurchase of 588,235 shares at $17.00 per share.$9,999,995.00
- GORDON CARL LPurchase of 300,249 shares at $17.00 per share.$5,104,233.00
- GORDON CARL LPurchase of 61,516 shares at $17.00 per share.$1,045,772.00
- GORDON CARL LPurchase of 588,235 shares at $17.00 per share.$9,999,995.00
- Chimovits ErezPurchase of 61,516 shares at $17.00 per share.$1,045,772.00
Surfaced by rule: 5 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.
Traded Sep 28, 2026 · Disclosed Sep 30, 2026
Source: SEC Form 4 · 0001193125-26-408061 · filed 2026-09-29 · View filing →
Source: SEC Form 4 · 0001193125-26-408064 · filed 2026-09-29 · View filing →
Source: SEC Form 4 · 0000947871-26-000910 · filed 2026-09-30 · View filing →
Source: SEC Form 4 · 0000947871-26-000911 · filed 2026-09-30 · View filing →
Source: SEC Form 4 · 0000947871-26-000912 · filed 2026-09-30 · View filing →